Thomas T. Vo
Chief Executive Officer at Nutex Health Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Nutex Health Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Nutex Health Inc. April 23, 202696.6%
-
Nutex Health Inc. June 14, 202481.3%
-
Nutex Health Inc. June 29, 202392.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 28, 2026 | Nutex Health Inc. | Other | +75,747 | — | — |
| Apr 9, 2026 | Nutex Health Inc. | Other | +184,071 | — | — |
| Mar 10, 2026 | Nutex Health Inc. | Option exercise | +8,334 | — | — |
| Mar 10, 2026 | Nutex Health Inc. | Shares withheld for tax | −3,017 | $86.22 | $260,126 |
| Apr 4, 2025 | Nutex Health Inc. | Shares withheld for tax | +895 | $72.10 | $64,530 |
| Mar 1, 2025 | Nutex Health Inc. | Option exercise | +5,000 | — | — |
| Jan 8, 2025 | Nutex Health Inc. | Gift | +5,000 | — | — |
| Jul 12, 2024 | Nutex Health Inc. | Grant or award | +22,709 | — | — |
| May 30, 2024 | Nutex Health Inc. | Open-market purchase | +2,986 | $0.66 | $1,971 |
| May 29, 2024 | Nutex Health Inc. | Open-market purchase | +3,768 | $0.68 | $2,562 |
| May 28, 2024 | Nutex Health Inc. | Open-market purchase | +48,394 | $0.70 | $33,876 |
| May 13, 2024 | Nutex Health Inc. | Open-market purchase | +17,330 | $0.69 | $11,958 |
| Nov 20, 2023 | Nutex Health Inc. | Open-market purchase | +275,200 | $0.23 | $63,296 |
| Nov 17, 2023 | Nutex Health Inc. | Open-market purchase | +224,800 | $0.23 | $51,704 |
| Aug 31, 2023 | Nutex Health Inc. | Open-market purchase | +152,326 | $0.28 | $42,651 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.